Evaluation of clinical use and effectiveness of darbepoetin alfa in cancer patients with chemotherapy-induced anemia

2011 ◽  
Vol 28 (1) ◽  
pp. 57-67 ◽  
Author(s):  
Aurelia Bustos ◽  
Ruth Álvarez ◽  
Pedro Miguel Aramburo ◽  
Francisco Carabantes ◽  
Nieves Díaz ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Darbepoetin Alfa ◽  
Clinical Use

Current practice of darbepoetin alfa in the management of haemoglobin levels in cancer patients undergoing chemotherapy – data from the CHOICE study

2011 ◽  
Vol 27 (5) ◽  
pp. 987-994 ◽  
Author(s):  
S. Van Belle ◽  
C. Karanikiotis ◽  
J.-L. Labourey ◽  
A. Galid ◽  
T. Wheeler ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Darbepoetin Alfa ◽  
Current Practice

scholarly journals Oral sucrosomial iron versus intravenous iron in anemic cancer patients without iron deficiency receiving darbepoetin alfa: a pilot study

2017 ◽  
Vol 25 (9) ◽  
pp. 2779-2786 ◽  
Author(s):  
Antonino Mafodda ◽  
D. Giuffrida ◽  
A. Prestifilippo ◽  
D. Azzarello ◽  
R. Giannicola ◽  
...  
Keyword(s):  
Pilot Study ◽  
Iron Deficiency ◽  
Cancer Patients ◽  
Darbepoetin Alfa ◽  
Intravenous Iron

PD-0357: Clinical use of iterative 4D CBCT reconstructions to investigate tumor motion of lung cancer patients

2014 ◽  
Vol 111 ◽  
pp. S137-S138
Author(s):  
M.L. Schmidt ◽  
T.S. Sørensen ◽  
D.C. Hansen ◽  
L. Hoffmann ◽  
J. Toftegaard ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cancer Patients ◽  
Clinical Use ◽  
Tumor Motion ◽  
Lung Cancer Patients

scholarly journals Donald Metcalf AC. 26 February 1929 — 15 December 2014

2016 ◽  
Vol 62 ◽  
pp. 409-431
Author(s):  
Nicos A. Nicola
Keyword(s):  
Growth Factors ◽  
Progenitor Cells ◽  
Human Health ◽  
Cancer Patients ◽  
Mechanisms Of Action ◽  
Clinical Use ◽  
Medical Researchers

Donald Metcalf was one of Australia's most distinguished medical researchers and is acknowledged internationally as the father of the modern field of haemopoietic growth factors. He defined the hierarchy of haemopoietic progenitor cells, purified and cloned the major molecular regulators of their growth and maturation, determined their mechanisms of action and participated in their development for clinical use in cancer patients. He received numerous awards and distinctions during his career, but was most pleased by the fact that his life's work improved human health.

Darbepoetin alfa in the treatment of anemia in cancer patients undergoing chemotherapy

2012 ◽  
Vol 12 (11) ◽  
pp. 1383-1390 ◽  
Author(s):  
Isabelle Wauters ◽  
Johan Vansteenkiste
Keyword(s):  
Cancer Patients ◽  
Darbepoetin Alfa
Sign in / Sign up

Export Citation Format

Share Document